Last reviewed · How we verify
NCT00519675
Open Label Treatment of Patients With Chronic Hand Dermatitis Who Have Participated in a Previous Clinical Trial Involving Oral Alitretinoin
Phase 3 trial testing alitretinoin in Eczema in 150 participants. Completed.
Quick facts
| Lead sponsor | Basilea Pharmaceutica |
|---|---|
| Phase | Phase 3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 1 May 2007 |
| Sites | 4 locations across France, Germany |
Drugs / interventions tested
- alitretinoin (ALITRETINOIN) — full drug profile →
Conditions studied
- Eczema — all drugs for Eczema →
Sponsor
Basilea Pharmaceutica — full company profile →
Who can join
Adults 18 to 80, any sex, with Eczema. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
- Safety assessments
Sponsor's own description
The purpose of the study is to investigate the safety and efficacy of alitretinoin in chronic hand eczema that is refractory to topical corticosteroids.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Retinoids as Chemo-Preventive and Molecular-Targeted Anti-Cancer Therapies.
Hunsu VO, Facey COB, Fields JZ, Boman BM. · · 2021 · cited 62× · PMID 34299349 · DOI 10.3390/ijms22147731
Verify or expand the search:
- PubMed search for NCT00519675
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of alitretinoin
Trials testing the same drug.
- NCT01245140 — Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis · Phase 2 · completed
- NCT00817063 — Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema · Phase 3 · completed
Other recruiting trials for Eczema
Currently open trials in the same condition.
- NCT07463079 — Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema · NA · recruiting
- NCT06807268 — A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema · Phase 3 · recruiting
- NCT07355075 — A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis) · Phase 2 · recruiting
- NCT06998446 — Sodium in the Skin and Atopic Dermatitis · recruiting
- NCT06994520 — Efficacy of Topical Cannabidiol for Eczema · Phase 2 · active not recruiting
Other Basilea Pharmaceutica trials
Trials by the same sponsor.
- NCT06961708 — A Study of Fosmanogepix in Healthy Adult Chinese Subjects · Phase 1 · completed
- NCT06808646 — A Study to Assess the Effect of Ceftobiprole on the PK of Pitavastatin and on Plasma Levels of Coproporphyrin · Phase 1 · completed
- NCT06733675 — Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination · Phase 1 · recruiting
- NCT05421858 — A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invas · Phase 3 · recruiting
- NCT06665555 — Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00519675 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Basilea Pharmaceutica
- Last refreshed: 9 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00519675.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing